Journal
NATURE REVIEWS GENETICS
Volume 12, Issue 4, Pages 231-242Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrg2937
Keywords
-
Categories
Funding
- Swiss National Science Foundation
- G. Harold and Leila Y. Mathers Charitable Foundation
- Cellex Foundation
- MICINN
- Sanofi-Aventis
Ask authors/readers for more resources
Pluripotent stem-cell lines can be obtained through the reprogramming of somatic cells from different tissues and species by ectopic expression of defined factors. In theory, these cells - known as induced pluripotent stem cells (iPSCs) - are suitable for various purposes, including disease modelling, autologous cell therapy, drug or toxicity screening and basic research. Recent methodological improvements are increasing the ease and efficiency of reprogramming, and reducing the genomic modifications required to complete the process. However, depending on the downstream applications, certain technologies have advantages over others. Here, we provide a comprehensive overview of the existing reprogramming approaches with the aim of providing readers with a better understanding of the reprogramming process and a basis for selecting the most suitable method for basic or clinical applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available